Medscape July 4, 2024
In 2018, Andrew Kraftson, MD, was approached by a colleague with a recurring dilemma: Primary care clinicians were both struggling with the complexities of obesity care, unsure how to best treat these patients and frustrated with an ineffective referral process.
Reflecting on his medical training in the early 2000s, Kraftson, a clinical associate professor of metabolism and endocrinology at the University of Michigan in Ann Arbor, recalled the sparse education on obesity — reduced to simplistic advice to “eat less and exercise more,” and brief references to bariatric surgery.
As medications like semaglutide have gained popularity in recent years, many primary care clinicians are uncertain about how to effectively manage these potent treatments and navigate their potential side effects.
“There...
Today's Sponsors
Today's Sponsor